These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36456936)

  • 1. Benefits from the first year of GnRHa therapy in boys with idiopathic central precocious puberty when initiating treatment after age 9 years: findings from a real-world retrospective study.
    Ni MM; Yang ST; Wu WW; Wang SS; Li M; Liu QQ; Ji X
    BMC Endocr Disord; 2022 Dec; 22(1):299. PubMed ID: 36456936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal assessment of auxological parameters, adult height outcome and its determinants in leuprolide-treated Indian girls with idiopathic central precocious puberty.
    Mondkar S; Khadilkar V; Yewale S; Dange N; More C; Khadilkar A
    J Pediatr Endocrinol Metab; 2024 Jan; 37(1):62-68. PubMed ID: 38008794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty.
    Pasquino AM; Municchi G; Pucarelli I; Segni M; Mancini MA; Troiani S
    J Clin Endocrinol Metab; 1996 Mar; 81(3):948-51. PubMed ID: 8772556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-releasing hormone analogue and recombinant human growth hormone treatment for idiopathic central precocious puberty in girls.
    Shi Y; Ma Z; Yang X; Ying Y; Luo X; Hou L
    Front Endocrinol (Lausanne); 2022; 13():1085385. PubMed ID: 36589818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined therapy with GnRH analog plus growth hormone in central precocious puberty.
    Pucarelli I; Segni M; Ortore M; Moretti A; Iannaccone R; Pasquino AM
    J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():811-20. PubMed ID: 10969926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of gonadotropin-releasing hormone analog combined with stanazolol on final height in girls with idiopathic central precocious puberty and apparent decrease of linear growth].
    Li YH; Zhu SY; Ma HM; Su Z; Chen HS; Chen QL; Gu YF; Du ML
    Zhonghua Er Ke Za Zhi; 2013 Nov; 51(11):807-12. PubMed ID: 24484553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
    Pasquino AM; Pucarelli I; Segni M; Matrunola M; Cerroni F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):449-52. PubMed ID: 10022399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final adult height in children with central precocious puberty - a retrospective study.
    Knific T; Lazarevič M; Žibert J; Obolnar N; Aleksovska N; Šuput Omladič J; Battelino T; Avbelj Stefanija M
    Front Endocrinol (Lausanne); 2022; 13():1008474. PubMed ID: 36531464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated versus slowly progressive forms of puberty in girls with precocious and early puberty. Gonadotropin suppressive effect and final height obtained with two different analogs.
    Lanes R; Soros A; Jakubowicz S
    J Pediatr Endocrinol Metab; 2004 May; 17(5):759-66. PubMed ID: 15237711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study of subcutaneous administration of gonadotropin-releasing hormone agonist every six weeks in girls with idiopathic central precocious puberty].
    Liang Y; Wei H; Zhang JL; Hou L; Luo XP
    Zhonghua Er Ke Za Zhi; 2004 Nov; 42(11):845-9. PubMed ID: 15631714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subnormal Growth Velocity and Related Factors During GnRH Analog Therapy for Idiopathic Central Precocious Puberty.
    Muratoğlu Şahin N; Uğraş Dikmen A; Çetinkaya S; Aycan Z
    J Clin Res Pediatr Endocrinol; 2018 Jul; 10(3):239-246. PubMed ID: 29687783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near final adult height, and body mass index in overweight/obese and normal-weight children with idiopathic central precocious puberty and treated with gonadotropin-releasing hormone analogs.
    Sinthuprasith P; Dejkhamron P; Wejaphikul K; Unachak K
    J Pediatr Endocrinol Metab; 2019 Dec; 32(12):1369-1375. PubMed ID: 31605579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Random Luteinizing Hormone is an Unreliable Indicator for Pubertal Suppression in Girls Treated with Monthly Leuprolide for Idiopathic Central Precocious Puberty.
    Wiromrat P; Panamonta O
    J Clin Res Pediatr Endocrinol; 2019 Sep; 11(3):227-233. PubMed ID: 30592192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of GnRHa 3.75 mg subcutaneously every 6 weeks on adult height in girls with idiopathic central precocious puberty.
    Liang Y; Wei H; Li J; Hou L; Zhang J; Wu W; Ying Y; Luo X
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):839-46. PubMed ID: 25719299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which parameters predict the beneficial effect of GnRHa treatment on height in girls with central precocious puberty?
    Vuralli D; Gonc NE; Ozon ZA; Kandemir N; Alikasifoglu A
    Clin Endocrinol (Oxf); 2021 May; 94(5):804-810. PubMed ID: 33460480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of leuprorelin 3-month depot (11.25 mg) for idiopathic central precocious puberty treatment of Chinese girls: a single-center retrospective study.
    Huang S; Zhang L; Gao C; Ou H; Hou L; Liu Z; Wang D; Xu Y; Liang L; Meng Z
    J Pediatr Endocrinol Metab; 2024 Jan; 37(1):15-20. PubMed ID: 37975727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of gonadotropin-releasing hormone agonist monotherapy and combination therapy with growth hormone on final adult height in girls with central precocious puberty.
    Cho AY; Shim YS; Lee HS; Hwang JS
    Sci Rep; 2023 Jan; 13(1):1264. PubMed ID: 36690835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of gonadotropin-releasing hormone agonist on final adult height among girls with early and fast puberty.
    Tseng CH; Lee YJ; Huang CY; Wu YL; Wang LT; Lin CH; Cheng BW; Lo FS; Chang YJ; Ting WH
    Front Endocrinol (Lausanne); 2023; 14():1271395. PubMed ID: 38027198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective evaluation of patients diagnosed with central precocious puberty who reached the final height.
    Yaman K; Unal E; Beştaş A; Aktar Karakaya A; Beyazıt N; Kolbaşı B
    J Pediatr Endocrinol Metab; 2024 Aug; 37(8):715-721. PubMed ID: 38881279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved final predicted height with the injection of leuprolide in children with earlier puberty: A retrospective cohort study.
    Lin YC; Lin CY; Chee SY; Yen HR; Tsai FJ; Chen CY; Wang CH
    PLoS One; 2017; 12(10):e0185080. PubMed ID: 28973010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.